Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Metabolic Syndrome and Obesity in Childhood and Adolescence

Editor(s): Kiess W. (Leipzig) 
Wabitsch M. (Ulm) 
Maffeis C. (Verona) 
Sharma A.M. (Edmonton, Alta.) 
Cover

Societal Aspects and Prevention

Metabolic Syndrome and the ‘Western Diet': Science and Politics

Lustig R.H.a, b

Author affiliations

aDivision of Pediatric Endocrinology, Department of Pediatrics, UCSF Benioff Children's Hospital and the bPhilip R. Lee Institute for Health Policy Studies, University of California, San Francisco, Calif., USA

Related Articles for ""

Kiess W, Wabitsch M, Maffeis C, Sharma AM (eds): Metabolic Syndrome and Obesity in Childhood and Adolescence. Pediatr Adolesc Med. Basel, Karger, 2015, vol 19, pp 137-147

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Complete book

  • Immediate access to all parts of this book
  • Cover-to-cover formats may be available
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restriction for personal use
read more

Pricing depends on hard-cover price


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Societal Aspects and Prevention

Published online: January 26, 2015
Cover Date: 2015

Number of Print Pages: 11
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-318-02798-3 (Print)
eISBN: 978-3-318-02799-0 (Online)

Abstract

Metabolic syndrome comprises a set of chronic diseases (hypertension, diabetes, dyslipidemia, and cardiovascular disease) that tend to cluster together. Although obesity is commonly thought to be the antecedent of metabolic syndrome, this syndrome also occurs in lean individuals, suggesting that obesity is a marker of metabolic syndrome rather than a cause. The cellular mechanisms of metabolic syndrome include mitochondrial overload, de novo lipogenesis, hepatic insulin resistance and hyperinsulinemia, reactive oxygen species formation, endoplasmic reticulum stress, and the unfolded protein response. Specific alterations of the Western Diet uniquely drive this process and are unrelated to calories. These alterations include too little fiber, omega-3 fatty acids, and micronutrients, and too many omega-6 fatty acids, trans-fats, branched-chain amino acids, ethanol, and fructose. The food industry invokes personal responsibility while denying any corporate responsibility and citing scientific, policy, and social arguments. However, their responses obfuscate the scientific truth in order to obviate their culpability.

© 2015 S. Karger AG, Basel


References

  1. Steinberger J, Daniels SR, Eckel RH, et al: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 2009;119:628-647.
  2. Garg A: Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220-1234.
  3. Reaven G: Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993;44:121-131.
  4. Haas JT, Biddinger SB: Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol 2009;20:206-210.
  5. Naïmi M, Gautier N, Chaussade C, Valverde AM, Accili D, Van Obberghen E: Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinol 2007;148:2424-2434.
  6. Sung KC, Kim SH: Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes. J Clin Endocrinol Metab 2011;96:1093-1097.
  7. Brown MS, Goldstein JL: Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7:95-96.
  8. D'Adamo E, Cali AM, Weiss R, et al: Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diab Care 2010;33:1817-1822.
  9. Fabbrini E, Magkos F, Mohammed BS, et al: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci 2009;106:15430-15435.
  10. Mollica MP, Lionetti L, Putti R, Cavaliere G, Gaita M, Barletta A: From chronic overfeeding to hepatic injury: role of endoplasmic reticulum stress and inflammation. Nutr Metab Cardiovasc Dis 2011;21:222-230.
  11. Hummasti S, Hotamisligil GS: Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 2010;107:579-591.
  12. Weickert MO, Pfeiffer AFH: Metabolic effects of dietary fiber consumption and prevention of diabetes. J Nutr 2008;138:439-442.
  13. Davì G, Santilli F, Patrono C: Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 2010;28:216-226.
  14. Newgard CB, An J, Bain JR, et al: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 2009;9:311-326.
  15. Bremer AA, Stanhope KL, Graham JL, et al: Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes. Clin Transl Sci 2011;4:243-252.
  16. Stanhope KL, Schwarz JM, Keim NL, et al: Consuming fructose-, not glucose-sweetened beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334.
  17. Nagai Y, Yonemitsu S, Erion DM, et al: The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 2009;9:252-264.
  18. EPIC-Interact Consortium: Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013;56:1520-1530.
  19. Basu S, Yoffe P, Hills N, Lustig RH: The relationship of sugar to population-level diabetes prevalence: an econometric analysis of repeated cross-sectional data. PLoS One 2013;8:e57873.
  20. Bremer AA, Mietus-Snyder ML, Lustig RH: Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012;129:557-570.
  21. Ruff JS, Suchy AK, Hugentobler SA, et al: Human-relevant levels of added sugar consumption increase female mortality and lower male fitness in mice. Nat Commun 2013;4:2245.
  22. Bose T, Chakraborti AS: Fructose-induced structural and functional modifications of hemoglobin: implication for oxidative stress in diabetes mellitus. Biochim Biophys Acta 2008;1780:800-808.
  23. Sievenpiper JL, de Souza RJ, Mirrahimi A, et al: Effect of fructose on body weight in controlled feeding trials: a systematic review and meta-analysis. Ann Int Med 2012;156:291-304.
  24. Parks EJ, Krauss RM, Christiansen MP, Neese RA, Hellerstein MK: Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance. J Clin Invest 1999;104:1087-1096.
  25. Hudgins LC, Parker TS, Levine DM, Hellerstein MK: A dual sugar challenge test for lipogenic sensitivity to dietary fructose. J Clin Endocrinol Metab 2011;96:861-868.
  26. Ng SW, Slining MM, Popkin BM: Use of caloric and noncaloric sweeteners in US consumer packaged foods, 2005-2009. J Acad Nutr Diet 2012;112:1828-1834.

Article / Publication Details

First-Page Preview
Abstract of Societal Aspects and Prevention

Published online: January 26, 2015
Cover Date: 2015

Number of Print Pages: 11
Number of Figures: 1
Number of Tables: 0

ISBN: 978-3-318-02798-3 (Print)
eISBN: 978-3-318-02799-0 (Online)


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.